Let's advance cell therapy together
Connect with Cellevolve to explore partnerships, investment opportunities, or learn how our novel cell therapies can address unmet medical needs.
Tell us about your interest
Share your name, email, and message. We'll respond promptly to discuss partnerships, investments, or our cell therapy work.
Leading cell therapy innovation
Cellevolve's team brings together expertise in cell biology, biomanufacturing, regulatory affairs, and clinical development to advance transformative therapies.
Chief Executive Officer
Dr. James Richardson
James leads Cellevolve's vision and strategy in cell therapy commercialization. He brings 15 years of biotech leadership experience, including previous roles at regenerative medicine companies.
Chief Scientific Officer
Dr. Priya Sharma
Priya oversees Cellevolve's platform development and research strategy. Her expertise spans cell engineering, biomanufacturing optimization, and translating basic science into clinical applications.
VP of Regulatory Affairs
Dr. Miguel Santos
Miguel manages regulatory strategy and compliance for Cellevolve's therapies. He has extensive experience navigating FDA pathways and international regulatory requirements for cell and gene therapies.
VP of Business Development
Keisha Johnson
Keisha identifies and builds partnerships with academic institutions, pharma companies, and healthcare systems. She has relationships across the cell therapy ecosystem and drives Cellevolve's collaboration strategy.
Director of Manufacturing
Dr. David Chen
David oversees Cellevolve's biomanufacturing platform and process development. His background includes process optimization and scale-up for advanced cell therapies, ensuring consistent quality and efficiency.
Chief Financial Officer
Linda McCarthy
Linda manages Cellevolve's finances, funding strategy, and operational planning. She brings experience in biotech financing and has led successful fundraising initiatives to support clinical development.
Advancing Cell Therapies With Real Impact
Healthcare professionals and research partners trust Cellevolve to deliver breakthrough cell therapies that address unmet medical needs and improve patient outcomes.
Cellevolve's manufacturing platform enabled us to scale our cell therapy research in ways we thought impossible. Their expertise accelerated our timeline to clinical trials by months.
Dr. Jennifer Walsh
Director of Translational Research, Stanford University
Working with Cellevolve transformed how we approach cell therapy manufacturing. Their biomanufacturing expertise and collaborative approach made all the difference in our program's success.
Dr. Marcus Johnson
Chief Scientific Officer, Regenerative Medicine Institute
Cellevolve's commitment to advancing cutting-edge treatments is evident in every partnership interaction. They understand the complexity of bringing cell therapies to market and deliver real solutions.
Patricia Chen
Vice President of Business Development, BioTherapeutics Partners
Their collaboration with our academic lab opened doors we didn't know existed. Cellevolve's platform made our research viable for patients who desperately need new treatment options.
Dr. Robert Patel
Lead Investigator, Stem Cell Research Lab, UCSF
We needed a manufacturing partner who understood both the science and the regulatory landscape. Cellevolve delivered expertise on both fronts and kept us on track throughout development.
Dr. Helen Rodriguez
President, Advanced Cell Therapies Foundation
Cellevolve's platform enabled us to move from concept to manufacturing scale faster than we anticipated. Their team's dedication to advancing patient outcomes is inspiring.
Dr. James Thompson
Director of Clinical Development, TechMed Innovation Labs
Answers about our cell therapies and partnerships
Find answers to common questions about Cellevolve's work, or reach out directly for more details.
What cell therapies does Cellevolve develop?
Cellevolve develops novel cell therapies to address unmet medical needs. Our advanced biomanufacturing platforms enable us to create cutting-edge treatments. We work with academic and industry partners to accelerate therapies from discovery through commercialization.
How can I learn more about your current therapies?
Visit our services page to explore our therapeutic focus areas and current pipeline. For detailed information about specific programs, contact us directly at email@mybusiness.com or call +12345678900.
Does Cellevolve partner with academic institutions?
Yes. Cellevolve actively collaborates with academic and industry partners to advance our research and development. These partnerships help us bring innovative treatments to patients faster and more efficiently.
How do I explore partnership opportunities with Cellevolve?
We're interested in working with research institutions, biotech companies, and healthcare organizations. Contact our team at email@mybusiness.com or +12345678900 to discuss potential collaboration opportunities.
Is Cellevolve open to investment?
Cellevolve welcomes inquiries from investors interested in our mission to advance cell therapy treatments. Reach out to discuss investment opportunities and our long-term vision for improving patient outcomes.
Where is Cellevolve located?
Cellevolve is based in San Francisco, California. Our headquarters location brings us close to leading research institutions and biotech innovation. Visit our location page or contact us for office details and directions.
Ready to connect?
Get in touch with our team to discuss therapies, partnerships, or investment.
Join Cellevolve's mission to transform patient outcomes
Partner with us, invest in breakthrough treatments, or learn how our cell therapies address unmet medical needs.